MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference

   PDF    Add to Briefcase

 

VALENCIA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes, will present on Thursday, January 12, 2017 at the 35th Annual J.P. Morgan Healthcare Conference at 10:00 AM (PST) at the Westin St. Francis Hotel in San Francisco, California. 

Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer.    

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.  MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Company Contact:
Rose Alinaya
SVP Finance
661-775-5300
ralinaya@mannkindcorp.com

MNKD

Exchange:
NASDAQ GM and TASE(US Dollar)

Price: 4.36

Change: 0.40 (8.316%)

Volume: 6,728,387

Data as of
10/18/2017 10:38 AM ET .
Minimum 20 minute delay.

Refresh Quote >

Locations

Learn more about MannKind's offices in the United States

Learn More